Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 456 participants.

Also called NCT01661231

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 456 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01661231
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria, Belgium, Germany, Switzerland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01661231. Allocation not applicable; no masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2015-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe
Acronym
BIOFLEX-I EU
Condition
Peripheral Artery Disease
Condition
Peripheral Vascular Disease
Intervention (Device)
Astron/Pulsar-18 stent
Lead sponsor
Biotronik AG (class: industry)
Collaborator
Biotronik, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01661231
Content hash
f6119db20b69eee9295e33b465bdb5215d4aa0cbd686843ca01e4be2285e99c8